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Introduction
During the last decade, there was a significant progress related 
to the knowledge of the mechanism of action of general anes-
thetic.  Cellular and molecular mechanisms underlying general 
anesthesia are not yet fully elucidated but general anesthetics 
seems to act in both presynaptic and postsynaptic molecular 
targets
[1–4].  There is now a great body of evidences that clini-
cal concentrations of most general anesthetics act on specific 
ligand-gated ion channels like GABA and glutamate receptors 
and/or other important ion channels, such as voltage gated 
sodium channels, potassium channels and HCN-pacemaker 
channels
[3].  Nevertheless, characterizing the molecular targets 
of general anesthetics has challenged many research groups 
over the years.
Propofol is one of the most widely used general anesthetic 
agent for induction and maintenance of anesthesia.  Previous 
works performed in central nervous system (CNS) synapses 
have shown an inhibition of calcium channels by propofol
[5–7].   
Other works showed that propofol inhibited calcium-depen-
dent glutamate release evoked by veratridine and 4-AP with 
greater potency than Na
+ channel-independent release evoked 
by KCl
[8, 9].  In addition, there were evidences in the literature 
suggesting that high doses of propofol might have a direct 
effect on Na
+ channels
[9–13].  
It is well described the sedative and hypnotic effects of 
propofol on CNS.  Nevertheless, there are few studies inves-
tigating its effect on neuromuscular transmission.  Indeed, 
it has been proposed that propofol has a dual effect on the 
neuromuscular junction.  Low concentrations of propofol 
stimulate skeletal muscle contractions elicited direct and indi-
rectly
[14] but high concentrations of this agent inhibit skeletal 
muscle contractions evoked direct and indirectly
[15, 16].  The 
mechanisms underlying the neuromuscular effects of propofol 
include reduction of muscular blood flow, a direct effect on 
the post-junctional membrane receptors, and reduction on ace-
tylcholine (ACh) release on the neuromuscular junction
[17–23].  
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FM1-43 is a fluorescent tool that has been used to study 
synaptic vesicle recycling at the neuromuscular junction
[24–26].   
The molecular characteristics of this fluorescent marker allow 
its internalization during synaptic vesicle endocytosis as well 
as its release during exocytosis
[25].  In the present work, we 
investigated the effect of propofol on synaptic vesicle exocyto-
sis, a crucial step for neurotransmitter release.  We used FM1-
43 to visualize the effect of several concentrations of propofol 
on spontaneous and evoked exocytosis at frog neuromuscular 
junction.  
Materials and methods
Reagents
FM1-43 was purchased from Molecular Probes (Eugene, OR, 
USA), d-tubocurarine, 4-aminopyridine (4AP), tetrodotoxin 
(TTX), 2APB, dantrolene and omega-conotoxin GVIA were 
purchased from Sigma-Aldrich (St Louis, MO, USA).  Propofol 
was obtained from Fresenius (Uppsala, Sweden) and azu-
molene was obtained from Proctor & Gamble (Norwich, NY, 
USA).  All other chemicals and reagents were of analytical 
grade.  All procedures were approved by the local animal care 
committee (CETEA-UFMG).
Staining and destaining with FM1-43
The frog neuromuscular junction has been an invaluable 
experimental model for elucidating many aspects of neu-
rotransmission which is the basis of neuronal communication.   
Two decades ago, Betz and colleagues have introduced the use 
of the fluorescent dye FM1-43 to visualize synaptic vesicles 
recycling in motor nerve terminals of the frog neuromuscu-
lar junction
[24, 25, 27].  Using this powerful tool, it was possible 
to elucidate the mechanisms that governed synaptic vesicle 
recycling and consequently neurotransmitter release in several 
neuronal cell types
[28].  
In the present work, frog cutaneous pectoris nerve muscle 
preparations were dissected from Rana catesbeiana (about 
60 g) and mounted in a sylgard-lined chamber containing 
frog Ringer solution (115 mmol/L NaCl, 2.5 mmol/L KCl, 
1.8 mmol/L CaCl2, 5 mmol/L HEPES, pH 7.2).  FM1-43 (4 
μmol/L) was used to stain the recycling pool of synaptic 
vesicles
[25].  This dye presents a hydrophobic tail that revers-
ibly binds to membranes and a polar head that impairs it to 
fully permeate the plasma membrane
[24–28].  Therefore, FM1-
43 binds to synaptic membrane and when the nerve terminal 
is submitted to a stimulus that causes exocytosis of synaptic 
vesicles and, consequently, a compensatory endocytosis, the 
fluorescent dye is incorporated, resulting in a typical pattern 
of staining
[25].  After a new round of stimulation, in the absence 
of FM1-43 in the external medium, the dye is released to the 
hydrophilic medium, resulting in a decrease of fluorescence 
intensity, reflecting the exocytosis of synaptic vesicle
[24–26].  In 
our experiments, the muscles were incubated with d-tubocu-
rarine (16 μmol/L) to prevent contractions during stimulation.   
The muscles were stimulated for 10 min with modified Ringer 
solution (57.5 mmol/L NaCl, 60 mmol/L KCl, 1.8 mmol/L 
CaCl2, 5 mmol/L HEPES, pH 7.2) in the presence of FM1-43 
(4 µmol/L).  Thereafter, the preparation was kept resting for 
15 min to guarantee FM1-43 uptake.  The excess of FM1-43 
adhered to the muscle membranes was removed during an 
one hour washing period in frog Ringer solution.  Images were 
acquired in intervals of 5 min until the end of the experiments.   
The destaining at the absence of stimulus (photobleaching) 
was used as a control.  
After labeling with FM1-43, neuromuscular preparations 
were exposed to different concentrations of propofol dur-
ing 30 min to evaluate its effect on spontaneous exocytosis.   
Experiments were also performed to investigate the effect of 
propofol on Na
+-dependent exocytosis evoked by 4AP.  After 
labeling neuromuscular preparations with FM1-43, muscles 
were exposed to 4AP (1 mmol/L) during 30 min.  To test the 
role of extracellular Na
+ on 4AP-evoked exocytosis, the neu-
romuscular preparation was initially incubated for 30 min 
in frog Ringer containing 1.0 µmol/L TTX and, thereafter, 
it was exposed to 4AP for 30 min.  The propofol effect on 
4AP-induced exocytosis was investigated by pre-incubation 
in propofol (100 µmol/L) solution during 10 min before 4AP 
exposure.  Similar protocols were applied to investigate the 
effects of propofol and TTX on Na
+-independent exocytosis 
evoked by 60 mmol/L KCl.
Experiments that investigated the role of extracellular Ca
2+ 
on the vesicular release induced by propofol were performed 
in modified Ringer solution without Ca
2+ but containing EGTA 
(2.0 mmol/L), an extracellular Ca
2+ chelator.  The prepara-
tions were incubated in modified Ringer during 30 min before 
application of propofol.  In experiments performed with the 
calcium channel blocker omega-conotoxin GVIA, the prepara-
tions were pre-incubated in Ringer containing toxin for 30 min 
before propofol.  The participation of intracellular Ca
2+ stores 
on the exocytosis evoked by propofol was also investigated.   
For this purpose, preparations were incubated for 30 min in 
Ringer containing 2APB (100 µmol/L), an IP3 receptor blocker, 
or azumolene (100 µmol/L), a ryanodine receptors blocker 
before the addition of propofol.  
Fluorescence microscopy and imaging analyses
Images were acquired using a fluorescence microscope (Zeiss 
Axioskop) coupled to a CCD camera (Micromax) and visual-
ized in a computer.  The microscope was equipped with water 
immersion objectives (63×, 0.95 NA and 40×, 0.75 NA).  Exci-
tation light came from a 100 W Hg lamp and passed through 
filters (505/530 nm) to select the fluorescence spectrum.  The 
experimental parameters for collection of images were always 
identical in control and test contralateral muscles in a given 
trial.  
Statistical analysis
Image analysis was performed using the softwares Image J 
and Microsoft Excel.  The mean fluorescence intensity was 
determined for each group of spots and plotted against the 
time as percentage of its mean initial fluorescence using the 
software Sigma Plot 9.0.  Statistical analysis was performed 
using paired Student’s t-Test or ANOVA.  P<0.05 values were 33
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considered statistically significant.
Results
FM1-43 staining and destaining of nerve terminals
Frog cutaneous-pectoris neuromuscular junctions were 
stained with FM1-43 as previously described
[25].  The nerve 
terminal that was stained with FM1-43 shows fluorescent 
spots corresponding to clusters of synaptic vesicles that were 
able to pick up the dye (Figure 1A, upper panel).  When this 
previously labeled terminal was submitted to a new depolar-
izing stimulus by modified Ringer containing 60 mmol/L KCl, 
in the absence of FM1-43 in external medium, we observed a 
significant reduction in fluorescence (Figure 1A, lower panel).   
The loss of fluorescence was due to dye release to external 
medium, that correspond to synaptic vesicle exocytosis
[25].   
Exposure of nerve terminals to illumination without any depo-
larizing stimulus resulted in a small decrease on fluorescence 
(maximum 10%) attributable to dye photobleaching
[28].  A 
representative image of the terminal before (upper panel) and 
after illumination (lower panel), in the absence of stimulus, 
is shown in Figure 1B.  To quantify the decrease in fluores-
cence that occurs after stimulation with 60 mmol/L KCl and 
photobleaching, the mean fluorescence intensity for each syn-
aptic vesicle cluster was measured and plotted as gray levels 
against time (Figure 1C).  The small reduction in fluorescence 
observed corresponds to photobleaching whereas the larger 
destaining curve obtained during depolarization stimulus cor-
responds to synaptic vesicle exocytosis.
Effect of low concentrations of propofol on spontaneous synaptic 
vesicle exocytosis
Nerve terminals labeled with FM1-43 were bathed in different 
concentrations of propofol (10 to 200 µmol/L) for 30 min (Fig-
ure 2).  Fluorescence of representative terminals before and 
after photobleaching (Figure 2A); propofol 10 µmol/L (Figure 
2B), and propofol 200 µmol/L (Figure 2C) were obtained.   
Low concentrations of propofol ranging from 10 to 25 µmol/L 
significantly reduced FM1-43 fluorescence, corresponding to 
exocytosis of previously labeled vesicular clusters (*P<0.01 
compared to photobleaching) (Figure 2D).  On the other hand, 
high doses of propofol (50–200 µmol/L) had no effect on FM1-
43 destaining from motor nerve terminals (Figure 2D), sug-
gesting a dose-dependent effect of the anesthetic agent.  
The next set of experiments was performed to identify the 
mechanism(s) by which low doses of propofol induced exo-
cytosis of synaptic vesicles.  Pre-incubation of nerve terminals 
with TTX (1.0 µmol/L), a voltage-gated Na
+-channel blocker, 
did not affect the vesicle exocytosis evoked by propofol (data 
not shown).  By contrast, the effect of low doses of propofol 
Figure 1.   Synaptic vesicles recycling visualized by the fluorescent 
dye FM1-43.  (A) Upper panel: Representative nerve terminal that 
was incubated in modified Ringer containing 60 mmol/L KCl for 10 
min in the presence of FM1-43.  Note the formation of fluorescent 
spots, corresponding to clusters of synaptic vesicles that were able to 
pick up dye.  Lower panel: The same terminal after a second round of 
depolarization with modified Ringer containing 60 mmol/L KCl, now in the 
absence of extracellular dye.  Note a pronounced destaining of fluorescent 
spots, corresponding to exocytosis of synaptic vesicles and dye release to 
the external medium.  (B) Representative image of fluorescence loss due 
to photobleaching during illumination for 30 min.  Upper panel: before 
illumination.  Lower panel: after 30 min of illumination.  (C) Quantification 
of FM1-43 fluorescence loss due to photobleaching and KCl fluorescence 
loss due to exocytosis of synaptic vesicles.  The results are mean±SEM of 
65 spots from 8 nerve terminals of 4 animals.  Scale Bar=10 µm.
Figure 2.  Dose-response curve of exocytosis induced by propofol.  (A) 
Representative image of fluorescence loss due to photobleaching during 
illumination for 30 min.  Upper panel: before illumination.  Lower panel: 
after 30 min of illumination.  (B) Representative image of fluorescence 
loss before (upper panel) and after (lower panel) 30 min in the presence 
of propofol 10 µmol/L.  (C) Representative image of fluorescence loss 
before (upper panel) and after (lower panel) 30 min in the presence of 
propofol 200 µmol/L.  (D) Quantification of exocytosis evoked by different 
concentrations of propofol.  The results are mean±SEM of 131 fluorescent 
spots from 15 nerve terminals of 8 animals.  
cP<0.01 compared to the 
second bar (photobleaching).  Scale Bar=10 µm.34
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on spontaneous exocytosis monitored by FM1-43 destain-
ing was Ca
2+-dependent (Figure 3A).  Indeed, we observed a 
statistically significant inhibition of exocytosis evoked by low 
doses of propofol in the presence of the external Ca
2+ chelator 
EGTA (2.0 mmol/L) or in the presence of omega-toxin GVIA 
(5 µmol/L), that blocks N-type calcium channels (Figure 3A).   
The FM1-43 destaining in the presence of GVIA was not signif-
icantly different from that due to photobleaching (P>0.05).  In 
addition, we observed that the effect of low doses of propofol 
on synaptic vesicles exocytosis was independent on intracel-
lular Ca
2+ stores (Figure 3B).  Our data suggest that FM1-43 
destaining induced by propofol (10 µmol/L) was Ca
2+ depen-
dent and Na
+-independent.  
Effects of high concentrations of propofol on exocytosis evoked 
by depolarizing stimuli
It has been shown that propofol at concentrations around 100 
µmol/L inhibits skeletal muscle evoked contractions
[15, 16].  We 
therefore tested in our system if this concentration of propo-
fol could alter with 4AP-evoked FM1-43 destaining, which 
is dependent on extracellular Na
+.  The incubation of nerve 
terminals with 4AP (1.0 mmol/L) during 30 min induced a 
significant FM1-43 destaining (Figure 4A).  The destaining 
evoked by 4AP was reduced by TTX (P<0.01 compared to 4AP 
alone).  Pre-incubation of FM1-43 stained nerve terminals with 
propofol (100 µmol/L) also reduced the 4AP-evoked exocy-
tosis (Figure 4A; P<0.01 compared to 4AP alone).  Moreover, 
the simultaneous pre-incubation with propofol (100 µmol/L) 
and TTX (1.0 µmol/L) produced a significant inhibition of 4AP 
evoked FM1-43 destaining without any additive effect (Figure 
4A), suggesting that propofol reduces the 4AP-induced vesicle 
exocytosis by blocking Na
+ channels sensitive to TTX.  
We next tested the effect of high doses of propofol on Na
+-
independent exocytosis evoked by modified Ringer containing 
60 mmol/L KCl.  Nerve terminals were stained with FM1-43 
Figure 3.  Low doses of propofol evoke synaptic vesicles exocytosis that 
is dependent on external calcium.  (A) FM1-43 destaining evoked by 
photobleaching (second bar), propofol (10 µmol/L) (third bar), propofol 
(10 µmol/L)+EGTA (2 mmol/L) (fourth bar), propofol (10 µmol/L)+GVIA (5 
µmol/L) (fifth bar).  Note that even though EGTA was apparently slightly 
less effective than GVIA, both agents inhibited the propofol-evoked 
destaining.  The results are mean±SEM of 192 fluorescent spots from 
20 nerve terminals of 10 animals.  
bP<0.05 compared to the second 
bar (photobleaching).  
fP<0.01 compared to propofol (10 µmol/L).  (B) 
FM1-43 destaining evoked by photobleaching (second bar), propofol (10 
µmol/L) (third bar), propofol (10 µmol/L)+azumolene (100 µmol/L) (fourth 
bar), propofol (10 µmol/L)+2APB (100 µmol/L) (fifth bar).  The results 
are mean±SEM of 237 fluorescent spots from 18 nerve terminals of 9 
animals.  
cP<0.01 compared to the second bar (photobleaching).  
Figure 4.  High doses of propofol inhibit synaptic vesicles exocytosis by 
a Na
+-dependent manner.  (A) Graphic comparing FM1-43 destaining 
evoked by photobleaching (second bar), 4AP (1 mmol/L, third bar), 4AP 
(1 mmol/L)+TTX (1 µmol/L) (fourth bar), 4AP (1 mmol/L)+propofol (100 
µmol/L) (fifth bar) and 4AP (1 mmol/L)+propofol (100 µmol/L)+TTX 
(1 µmol/L) (sixth bar).  The results are mean±SEM of 114 fluorescent 
spots from 10 nerve terminals of 5 animals.  
bP<0.05 compared to the 
second bar (photobleaching).  
fP<0.01 compared to 4AP (1 mmol/L). (B) 
Quantification of exocytosis evoked by photobleaching (second bar), KCl (60 
mmol/L) (third bar); KCl (60 mmol/L)+propofol (100 µmol/L) (fourth bar); 
KCl (60 mmol/L)+TTX (1 µmol/L) (fifth bar). The results are mean±SEM   
of 120 fluorescent spots from 10 nerve terminals of 5 animals.  
cP<0.01 
compared to the second bar (photobleaching). 35
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and we observed a significant reduction on fluorescence after 
incubation with KCl for 30 min (Figure 4B).  Pre-incubation of 
terminals with TTX had no effect on KCl-evoked reduction in 
fluorescence, confirming the data that depolarization induced 
by high concentration of K
+ is independent of extracellular 
Na
+ [29] (Figure 4B).  In addition, pre-incubation with high 
doses of propofol did not inhibit KCl-evoked Na
+-independent 
exocytosis (Figure 4B).  Taken together, these results suggest 
that high doses of propofol inhibit synaptic vesicles exocytosis 
on the neuromuscular junction by a Na
+-dependent manner.  
Discussion
Propofol is widely used during general anesthesia, as well as 
for sedation in the intensive care unit.  However, fatigue of 
the respiratory muscles, especially the diaphragm, may cause 
respiratory failure.  Indeed, it has been demonstrated that 
volatile (halothane, enflurane, isoflurane, and sevoflurane) 
and intravenous (propofol and midazolam) anesthetics cause 
diaphragmatic contractile dysfunction which may probably 
contributes to acute respiratory failure
[19–21, 30–32].  Studies in vivo 
suggested that several mechanisms such as reduction of blood 
flow, failure of neuromuscular transmission, and impairment 
of membrane excitation and excitation-contraction (E–C) 
coupling may be responsible for the neuromuscular effects 
of propofol.  However, in vivo studies preclude any specifi-
cation regarding the mechanism involved on the anesthetic 
effect and the use of the fluorescent probe FM1-43 enabled 
us to assess specifically a presynaptic effect of this agent on 
the neuromuscular junction.  Hemmings et al
[30] had already 
performed a pioneer study on cultured hippocampal neurons 
using this fluorescent dye to probe synaptic vesicles exocytosis 
in the presence of isoflurane and they showed that isoflurane 
depresses exocytosis evoked by multiple presynaptic targets.  
In the present work, we examined the effect of propofol on 
spontaneous and evoked synaptic vesicle exocytosis at the 
neuromuscular junction, an experimental model that provides 
a direct way to investigate neurotransmitter release in an iso-
lated synapse.  We found that propofol, at low concentrations 
ranging from 10 to 25 µmol/L, induced synaptic vesicles exo-
cytosis monitored by FM1-43 destaining on a Ca
2+-dependent 
and Na
+-independent manner.  By contrast, high concentra-
tions of propofol ranging from 50 to 200 µmol/L were ineffec-
tive to induce synaptic vesicle exocytosis.  
It is well known that exocytosis depends on external Ca
2+[23] 
and we observed that in the absence of this ion, there was a 
significant reduction on FM1-43 destaining evoked by low 
doses of propofol, suggesting that synaptic vesicles exocytosis 
evoked by propofol is Ca
2+-dependent.  In addition, we inves-
tigated which calcium channel subtype could be the target 
of low doses of propofol at the frog neuromuscular junction 
and we observed an inhibition of propofol evoked exocyto-
sis in the presence of the N-type inhibitor omega-conotoxin 
GVIA.  Because the FM1-43 destaining evoked by propofol in 
the presence of GVIA was similar to that due to photobleach-
ing (P>0.05) , we suggest that propofol might act on N-type 
calcium channels promoting calcium influx that is coupled to 
synaptic vesicles exocytosis.  Different from our data, previous 
works performed in CNS synapses have shown a predominant 
inhibition of calcium channels by propofol
[5–7].  However, none 
of them have shown evidences that N-type calcium channels 
could be a target for propofol action.  This discrepancy might 
be due to the fact that these studies were performed in brain 
slices that maintain intact neuronal circuitry whereas in the 
present work we were looking at nerve terminals without con-
nection with motor neuron cell bodies.  Therefore, we cannot 
rule out the possibility that propofol may exert an inhibitory 
effect on calcium channels located at motor neurons’ cell bod-
ies that are located at the spinal cord.  Because we are look-
ing at events that take place exclusively at the synaptic nerve 
terminal, such inhibition would not be detected in our experi-
mental model.  Nonetheless, our data provide direct evidences 
that low doses of propofol might act through N-type calcium 
channel that are directly coupled to synaptic vesicle exocy-
tosis at motor nerve terminals.  Moreover, we showed that 
propofol and KCl-evoked exocytosis were not affected by TTX 
suggesting that both conditions did not increase the synaptic 
vesicle exocytosis by interfering with Na
+ channels.  Therefore, 
propofol and KCl can induce exocytosis in a Ca
2+-dependent 
and Na
+-independent fashion suggesting that this anesthetic 
may act directly on Ca
2+ entry through N-type voltage-gated 
Ca
2+ channels.
In agreement with our data, it has been observed that low 
concentrations of propofol increased the amplitude of the indi-
rectly-elicited twitch and tetanic contractions in chick biventer 
cervices skeletal muscle, indicating that, in low concentrations, 
this anesthetic may stimulate skeletal muscle
[14].  
Previous work showed that propofol, at concentrations of 
42 and 112 µmol/L, inhibited contraction of isolated rat dia-
phragm by decreasing ACh release on neuromuscular junc-
tion
[16].  These authors also observed that this agent inhibited 
muscle contraction evoked by electrical field stimulation, sug-
gesting that propofol, at this concentration range, may act by 
inhibiting Ca
2+ entry through presynaptic voltage-gated Ca
2+ 
channels.  In the present work high doses of propofol inhibited 
Na
+-dependent exocytosis evoked by 4AP but did not have 
any significant effect on Na
+-independent exocytosis evoked 
by KCl.  The decrease on vesicle exocytosis induced by 4AP 
in the presence of high doses of propofol is in correspondence 
with data showing a decreasing on the contractility of fatigued 
canine diaphragm with propofol in a dose-related fashion
[21].   
Previous studies in rat brain synaptosomes showed that 
propofol inhibits Ca
2+-dependent glutamate release evoked by 
veratridine and 4-AP with greater potency than Na
+ channel-
independent release evoked by KCl
[33–36].  In addition, it has 
been observed that high concentrations of propofol selectively 
inhibited 4AP-evoked but not KCl-evoked [
3H]norepinephrine 
release
[37].  Considering that high doses of propofol inhibited 
4AP-evoked synaptic vesicles exocytosis in a similar manner 
to TTX and did not interfere with KCl-evoked exocytosis, we 
could suggest that the effect of propofol on neuromuscular 
junction is thus caused primarily by inhibition of action poten-
tial-evoked synaptic vesicle exocytosis at a step upstream of 36
www.nature.com/aps
Leite LF et al
Acta Pharmacologica Sinica
npg
Ca
2+ entry through voltage-gated Ca
2+ channels, possibly as 
a result of Na
+ channel blockade.  In addition, there are evi-
dences in the literature suggesting that high doses of propofol 
might have a direct effect on Na
+ channels
[10, 12, 13].  Finally, 
experiments in dogs show that administration of propofol 
decreases diaphragm contractility in a dose-dependent man-
ner and that high dose of this anesthetic produces a progres-
sive decrease in contractility
[18].  Based on the data presented 
here, we could speculate that such diaphragmatic dysfunction 
might be due to a presynaptic effect of high doses of propo-
fol.  In addition, propofol and midazolam seems to cause 
diaphragm dysfunction through mechanisms other than E–C 
coupling failure
[23].  However, the clinical importance of the 
present data requires further investigations and we are unable 
to extrapolate our in vitro findings to the clinical practice.
It is difficult to correlate the concentrations of anesthetics 
used in vitro experiments with those used during clinical anes-
thesia and it has been shown that the doses of intravenous 
anesthetics required in the case of experimental animals are 
10-100 times higher than those used for humans
[38].  Plasma 
concentrations of propofol during anesthesia in humans are 
estimated to range between 70 and 106 µmol/L
[35, 39–41].  Because 
of the high protein binding (98%), the half-maximal effect free 
concentration of propofol is around 2.0 µmol/L
[35, 42, 43].  It has 
been suggested that brain concentrations of propofol are about 
eight-fold higher than plasma free concentrations
[44] but there 
is no estimative of the concentrations on neuromuscular junc-
tion.  Moreover, the propofol concentration producing loss 
of righting reflex in Rana pipiens tadpoles ranged between 1 
and 10 µmol/L
[45] an end point that usually occurs at a lower 
concentration than surgical anesthesia.  Finally, it has been 
argued that clinically relevant concentrations are difficult to 
estimate
[1-4] and it is important to mention that clinically rele-
vant concentrations of anesthetic are important to examine the 
integrated responses in the intact animal but their relevance 
to in vitro studies should be taken with care due to our lack 
of understanding of how to integrate in vitro systems into the 
anesthesia model
[46].  
In conclusion, we showed that propofol has a dual effect on 
the exocytosis of cholinergic synaptic vesicles from the neuro-
muscular transmission and the present results may contribute 
to understanding some of the clinical effects observed with 
this agent on neuromuscular function.  
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